172 related articles for article (PubMed ID: 29360808)
1. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
2. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
[TBL] [Abstract][Full Text] [Related]
3. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
Kim HJ; Choi EH; Kil HR
J Korean Med Sci; 2014 Oct; 29(10):1385-90. PubMed ID: 25368492
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
5. Plasma Endothelial Microparticles, TNF-a and IL-6 in Kawasaki Disease.
Tan Z; Yuan Y; Chen S; Chen Y; Chen TX
Indian Pediatr; 2013 May; 50(5):501-3. PubMed ID: 23255681
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
7. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
[TBL] [Abstract][Full Text] [Related]
9. [Changes of serum 25-hydroxyvitamin D3 and interleukin-6 after treatment with intravenous immunoglobulins in children with Kawasaki disease].
Chen Y; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1230-2. PubMed ID: 25176105
[TBL] [Abstract][Full Text] [Related]
10. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
11. Circulating adiponectin levels in Kawasaki disease.
Takeshita S; Takabayashi H; Yoshida N
Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
[TBL] [Abstract][Full Text] [Related]
12. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.
Furukawa S; Matsubara T; Yone K; Hirano Y; Okumura K; Yabuta K
Eur J Pediatr; 1992 Jan; 151(1):44-7. PubMed ID: 1728545
[TBL] [Abstract][Full Text] [Related]
16. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
[TBL] [Abstract][Full Text] [Related]
17. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].
Matsubara T
Arerugi; 1991 Feb; 40(2):147-54. PubMed ID: 2069514
[TBL] [Abstract][Full Text] [Related]
19. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
